Register Login
Register to leave comments
  • News bot March 26, 2026, 8:08 p.m.

    📋 SPYGLASS PHARMA, INC. (SGP) - Financial Results

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 16:06:24

    Event Type: Financial Results

    Event Details:

    SPYGLASS PHARMA, INC. (SGP) Reports the reporting period Financial Results SPYGLASS PHARMA, INC. (SGP) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 96358
      • “2025 was an important year for SpyGlass, as we advanced the development of our BIM
      • IOL System, including the initiation of two Phase 3 trials. We look forward to bringing our innovative technology to more patients and more surgeons,” stated Patrick Mooney, chief executive officer of SpyGlass Pharma. “2026 is off to an exceptional start, highlighted by our successful IPO that funds the Phase 3 trials of the BIM
      • IOL System as well as the planned initiation of a first
        • expected in 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations -7.75K -41.45K $33.70K +81.29%
    Other Income Expense Interest Income 207.00 3.11K $-2.90K -93.34%
    Other Income Expense Total Other Income Expense -645.00 1.58K $-2.23K -140.82%
    Current Assets Prepaid Expenses Other Current Assets 901.00 715.00 $186.00 +26.01%
    Current Assets Property Equipment Net 2.34K 2.17K $171.00 +7.89%
    Current Liabilities Accounts Payable 2.70K 2.70K $0.00 +0.00%
    Loss from Operations -13.63K -7.75K $-5.87K -75.75%
    Interest Income 1.07K 207.00 $866.00 +418.36%
    Net Loss -12.55K -12.55K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 901.00 715.00 $186.00 +26.01%
    Property and Equipment, Net 2.34K 2.17K $171.00 +7.89%
    Accounts Payable 2.70K 2.70K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SPYGLASS PHARMA, INC.
    • Ticker Symbol: SGP

Search

News categories